Agape ATP (ATPC) Competitors

Exagen (NASDAQ:XGN) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Which has more volatility & risk, XGN or ATPC?

Exagen has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.98, meaning that its share price is 198% less volatile than the S&P 500.

Which has better valuation & earnings, XGN or ATPC?

Agape ATP has lower revenue, but higher earnings than Exagen. Exagen is trading at a lower price-to-earnings ratio than Agape ATP, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exagen	$55.64M	3.78	-$15.11M	-$0.89	-10.74
Agape ATP	$1.32M	48.87	-$2.47M	-$0.41	-3.15

Do institutionals & insiders believe in XGN or ATPC?

75.3% of Exagen shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 12.6% of Exagen shares are held by insiders. Comparatively, 9.7% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the media prefer XGN or ATPC?

In the previous week, Exagen had 12 more articles in the media than Agape ATP. MarketBeat recorded 14 mentions for Exagen and 2 mentions for Agape ATP. Exagen's average media sentiment score of 1.01 beat Agape ATP's score of 0.95 indicating that Exagen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exagen	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Agape ATP	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer XGN or ATPC?

Exagen presently has a consensus target price of $12.00, indicating a potential upside of 25.52%. Given Exagen's stronger consensus rating and higher probable upside, equities analysts clearly believe Exagen is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exagen	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00
Agape ATP	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is XGN or ATPC more profitable?

Exagen has a net margin of -28.85% compared to Agape ATP's net margin of -183.13%. Agape ATP's return on equity of -20.32% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exagen	-28.85%	-130.38%	-34.69%
Agape ATP	-183.13%	-20.32%	-18.55%

Summary

Exagen beats Agape ATP on 10 of the 16 factors compared between the two stocks.